High CD30 ligand expression by epithelial cells and Hassal's corpuscles in the medulla of human thymus

Blood

Volumn 91, Issue 9, 1998, Pages 3323-3332

  Romagnani, Paola ^b   Annunziato, Francesco ^b   Manetti, Roberto ^b   Mavilia, Carmelo ^b   Lasagni, Laura ^b   Manuelli, Cinzia ^b   Vannelli, Gabriella B ^b   Vanini, Vittorio ^b   Maggi, Enrico ^b   Pupilli, Cinzia ^b   Romagnani, Sergio ^a  

^a Ist Med Int e Immunoallergologia   (Italy)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CD30 ANTIGEN; INTERLEUKIN 4; TUMOR NECROSIS FACTOR ALPHA;

ANTIGEN EXPRESSION; ARTICLE; CELL DEATH; CELL DIFFERENTIATION; EPITHELIUM CELL; GENE DELETION; HUMAN; HUMAN CELL; LIGAND BINDING; LYMPHOBLASTOID CELL; LYMPHOID TISSUE; PRIORITY JOURNAL; REED STERNBERG CELL; T LYMPHOCYTE ACTIVATION; THYMOCYTE; THYMUS; VIRUS TRANSFORMATION;

EID: 0032079762     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v91.9.3323.3323_3323_3332     Document Type: Article

References (30)

1. Smith CA, Davis T, Andersen D, Solam L, Beckmann MP, Jerzy R, Dower SK, Cosman D, Goodwin RG: A receptor for tumor necrosis factor defines an unusual family of cellular and viral proteins. Science 248:1019, 1990
2. Schwab U, Stein H, Gerdes J, Lemke H, Kirchner H, Schaadt M, Diehl V: Production of a monoclonal antibody specific for Hodgkin and Sternberg-Reed cells of Hodgkin's disease and a subset of normal lymphoid cells. Nature 299:65, 1982
3. Stein H, Mason DY, Gerdes J, O'Connor N, Wainscoat J, Pallesen G, Gatter K, Falini B, Delson G, Lemke H, Schwarting R, Lennert K: The expression of Hodgkin's disease associated antigen Ki-1 in reactive and neoplastic lymphoid tissue: Evidence that the Reed Sternberg cells and histiocytic malignancies are derived from activated lymphoid cells. Blood 66:848, 1985
4. Manetti R, Annunziato F, Biagiotti R, Giudizi M-G, Piccinni M-P, Giannarini L, Sampognaro S, Parronchi P, Vinante F, Pizzolo G, Maggi E, Romagnani S: CD30 expression by CD8+ T cells producing type 2 helper cytokines. Evidence for large numbers of CD8+CD30+ T cell clones in human immunodeficiency virus infection. J Exp Med 180: 2407, 1994
5. Del Prete GF, De Carli M, Almerigogna F, Daniel CK, D'Elios MM, Zancuoghi G, Vinante F, Pizzolo G, Romagnani S: Preferential expression of CD30 by human CD4+ T cells producing Th2-type cytokines. FASEB J 9:81, 1995
6. Chilosi M, Facchetti F, Notarangelo LD, Romagnani S, Del Prete GF, Almerigogna F, De Carli M, Pizzolo G: CD30 cell expression and abnormal soluble CD30 serum accumulation in Omenn's syndrome. Evidence for a Th2-mediated condition. Eur J Immunol 26:329, 1996
7. D'Elios MM, Romagnani P, Scaletti C, Annunziato F, Manghetti M, Mavilia C, Parronchi P, Pupilli C, Pizzolo G, Maggi E, Del Prete GF, Romagnani S: In vivo CD30 expression in human diseases with predominant activation of Th2-like T cells. J Leukoc Biol 61:539, 1997
8. Nakamura T, Lee RK, Nam SY, Al-Ramadi BK, Koni PA, Bottomly K, Podack ER, Flavell RA: Reciprocal regulation of CD30 expression on CD4+ T cells by IL-4 and IFN-y. J Immunol 158:2090, 1997
9. Smith CA, Gruss H-J, Davis T, Anderson D, Farrah T, Baker E, Sutherland GR, Brannan CI, Copeland NG, Jenkins NA, Grabstein KH, Gliniak B, McAllister IB, Fanslow W, Alderson M, Falk B, Gimpel S, Gillis S, Din WS, Goodwin RG, Armitage RJ: CD30 antigen, a marker for Hodgkin's lymphoma, is a receptor whose ligand defines an emerging family of cytokines with homology to TNF. Cell 73:1349, 1993
10. Younes A, Consoli U, Zhao S, Snell V, Thoma E, Gruss H, Cabanillas FV, Andreeff M: CD30 ligand is expressed on resting normal and malignant B lymphocytes. Br J Haematol 93:569, 1996
11. Gruss H, Pinto A, Gloghini A, Wehnes E, Wright B, Boiani M, Aldinucci D, Gattei V, Zagonel V, Smith CA, Kadin ME, Von Schilling C, Goodwin RG, Herrmann F, Carbone A: CD30 ligand expression in nonmalignant and Hodgkin's disease-involved lymphoid tissues. Am J Pathol 149:469, 1996
12. Gruss H, Boiani N, Williams DE, Armitage RJ, Smith CA, Goodwin RG: Pleiotropic effects of the CD30 ligand on CD30-expressing cells and lymphoma cell lines. Blood 83:2045, 1994
13. Amakawa R, Hakem A, Kundig TM, Matsuyama T, Simard JJL, Timms E, Wakeham A, Mittruecker H-W, Griesser H, Takimoto H, Schmits R, Shahinian A, Oshaki PS, Penninger JF, Mak TW: Impaired negative selection of T cells in Hodgkin's disease antigen CD30-deficient mice. Cell 84:551, 1996
14. Miltenyi S, Muller W, Weichel W, Radbruch A: High gradient magnetic cell separation with MACS. Cytometry 11:231, 1990
15. Fernandez E, Vicente A, Zapata A, Brera B, Lozano JL, Carlos-Martinez A, Toribio ML: Establishment and characterization of cloned human thymic epithelial cell lines. Analysis of adhesion molecule expression and cytokine production. Blood 83:3245, 1994
16. van Det NF, van der Born J, Tamsma JT, Verhagen NAM, van den Heuvel LPWJ, Berden JHM, Bruijn JA, Daha MR, van der Woude FJ: Proteoglycan production by human glomerular visceral epithelial cells and mesangial cells in vitro. Biochem J 307:759, 1995
17. Sanger F, Nicklen S, Coulson AR: DNA sequencing with chain-terminating inhibitors. Proc Natl Acad Sci USA 74:5463, 1997
18. Pupilli C, Brunori M, Misciglia N, Selli C, Ianni L, Yanagisaw M, Mannelli M, Serio M: Presence and distribution of endothelin-1 gene expression in human kidney. Am J Physiol 267:F679, 1994
19. Parronchi P, Romagnani P, Annunziato F, Sampognaro S, Becchio A, Giannarini L, Maggi E, Pupilli C, Tonelli F, Romagnani S: Type 1 T helper (Thl)-cell predominance and IL-12 expression in the gut of patients with Crohn's disease. Am J Pathol 150:823, 1997
20. Gavrieli Y, Sherman Y, Ben Sasson SA: Identification of programmed cell death in situ via specific labelling of nuclear DNA fragmentation. J Cell Biol 119:493, 1992
21. Annunziato F, Manetti R, Cosmi L, Galli G, Heusser CH, Romagnani S, Maggi E: Opposite role for interleukin 4 and Interferon-y on CD30 and lymphocyte activation gene-3 (LAG-3) expression by activated naive T cells. Eur J Immunol 27:2239, 1997
22. Ohara J, Paul WE: Up-regulation of interleukin-4/B-cell stimulatory factor 1 receptor expression. Proc Natl Acad Sci USA 85:8221, 1988
23. Renz H, Domenico J, Gelfand EW: IL-4-dependent up-regulation of IL-4 receptor expression in murine T and B cells. J Immunol 146:3049, 1991
24. Nakamura T, Kamogawa Y, Bottomly K, Flavell RA: Polarization of IL-4- and IFN-gamma-producing CD4+ T cells following activation of naive CD4+ T cells. J Immunol 158:1085, 1997
25. Haynes BF, Scearce RM, Lobach DF, Hensley LL: Phenotypic characterization and ontogeny of mesodermal-derived and endocrine epithelial components of the human thymic microenvironment. J Exp Med 159:1149, 1984
26. Bowen MA, Lee RK, Miragliotta G, Nam SY, Podack ER: Structure and expression of murine CD30 and its role in cytokine production. J Immunol 156:442, 1996
27. Murphy KM, Heimberger AB, Loh DY: Induction by antigen of intrathymic apoptosis of CD4+CD8+TCR1o thymocytes in vivo. Science 250:1720, 1990
28. Surh CD, Sprent J: T-cell apoptosis detected in situ during positive and negative selection in the thymus. Nature 372:100, 1994
29. Spits H, Lanier LL, Philips JH: Development of human T and natural killer cells. Blood 85:2654, 1995
30. Wiley SR, Goodwin RG, Smith CA: Reverse signaling via CD30 ligand. J Immunol 157:3635, 1996